Reports and Briefs on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

F. Hoffmann-La Roche Ltd: PharmaVitae Report

Analysis of Roche's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
06 Jun 2011 $2800
Buy
Report
Report

Cephalon Inc.: PharmaVitae Report

Analysis of Cephalon's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
10 Jun 2011 $2800
Buy
Report
Report

Amgen Inc.: PharmaVitae Report

Analysis of Amgen's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Jun 2011 $2800
Buy
Report
Report

Eli Lilly & Co.: PharmaVitae Report

Analysis of Eli Lilly's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Biogen Idec Inc.: PharmaVitae Report

Analysis of Biogen Idec's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Sanofi: PharmaVitae Report

Analysis of Sanofi corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Forest Laboratories Inc.: PharmaVitae Report

Analysis of Forest's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Merck & Co., Inc.: PharmaVitae Report

Analysis of Merck & Co.'s corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
29 Jun 2011 $2800
Buy
Report
Report

Turkey: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
29 Jun 2011 $1520
Buy
Report
Report

Turkey: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Turkey.

Published By Datamonitor
29 Jun 2011 $1520
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.